A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma

Update Il y a 4 ans
Reference: NCT00426764

Woman and Man

Extract

The purpose of this study is to evaluate the activity of romidepsin in patients with progressive or relapsed peripheral T-cell lymphoma (PTCL) who have already been treated with systemic therapy.


Inclusion criteria

  • Peripheral T-Cell Lymphoma


Links